Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-427965
Filing Date
2013-11-05
Accepted
2013-11-05 17:21:22
Documents
12
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d598039d10q.htm 10-Q 626904
2 EX-10.1 d598039dex101.htm EX-10.1 43804
3 EX-31.1 d598039dex311.htm EX-31.1 6211
4 EX-31.2 d598039dex312.htm EX-31.2 6139
5 EX-32.1 d598039dex321.htm EX-32.1 4688
12 GRAPHIC g598039img001.jpg GRAPHIC 5694
  Complete submission text file 0001193125-13-427965.txt   3726850

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acrx-20130930.xml EX-101.INS 532962
7 XBRL TAXONOMY EXTENSION SCHEMA acrx-20130930.xsd EX-101.SCH 32379
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20130930_cal.xml EX-101.CAL 42510
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20130930_def.xml EX-101.DEF 184047
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20130930_lab.xml EX-101.LAB 252156
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20130930_pre.xml EX-101.PRE 214856
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 131193676
SIC: 2834 Pharmaceutical Preparations